Ganga Pharma.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE615T01017
  • NSEID:
  • BSEID: 539680
INR
12.00
0.00 (0.00%)
BSENSE

Feb 12

BSE+NSE Vol: 8000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1000215,
    "name": "Ganga Pharma.",
    "stock_name": "Ganga Pharma.",
    "full_name": "Ganga Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/ganga-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "12.00",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "12.00",
    "mcapval": "7.00 Cr",
    "mcap": "",
    "scripcode": 539680,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE615T01017",
    "curr_date": "Feb 12",
    "curr_time": "",
    "bse_nse_vol": 8000,
    "exc_status": "Active",
    "traded_date": "Feb 12, 2026",
    "traded_date_str": "2026 02 12",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/ganga-pharma-1000215-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 0,
    "sid": "1000215",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/ganga-pharmaceuticals-1000215"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "26-Mar-2026",
      "details": "Intimation of Closure of Trading Window",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "16-Mar-2026",
      "details": "Newspaper Publication regarding special window for re-lodgement of transfer and dematerialisation request(s) of physical securities",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
      "datetime": "10-Mar-2026",
      "details": "Re-appointment of Mr. Bharat Brijmohan Sharma as Managing Director for a further period of Three years effective from April 01 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}
stock newsNews and Views
Icon
No Recent News for the Company
stock-recommendationAnnouncement

Closure of Trading Window

26-Mar-2026 | Source : BSE

Intimation of Closure of Trading Window

Announcement under Regulation 30 (LODR)-Newspaper Publication

16-Mar-2026 | Source : BSE

Newspaper Publication regarding special window for re-lodgement of transfer and dematerialisation request(s) of physical securities

Announcement under Regulation 30 (LODR)-Change in Directorate

10-Mar-2026 | Source : BSE

Re-appointment of Mr. Bharat Brijmohan Sharma as Managing Director for a further period of Three years effective from April 01 2026

stock-recommendationCorporate Actions
Corporate Actions
info
Icon
No corporate action available